-
Oncogenic Ectodomain deletion of FGFR1 caused by Breakage-Fusion-Bridges in Squamous Cell lung Cancer
Study
EGAS00001005059
-
Mutant p53 confers gain-of-function transcriptional activity in liver cancer
Study
EGAS00001005779
-
Unraveling the genetics of transformed splenic marginal zone lymphoma
Study
EGAS00001006389
-
Leukemia sequencing study
Study
EGAS00001006901
-
Detection of rare mutations, copy number variation, and DNA methylation in the same template DNA molecules
Study
EGAS00001006839
-
Targeted sequence of MDS cases treated with azacitidine
Study
EGAS00001007030
-
Molecular Classification of Lymph Node Metastases Subtypes Predict for Survival in Head and Neck Cancer
Study
EGAS00001003233
-
SCANDARE MACARON
Study
EGAS50000000145
-
The INFORM Precision Medicine Study for High-Risk Pediatric Malignancies
Study
EGAS00001005112
-
Correlative Genomic Analysis of Durvalumab plus Pazopanib Combination in Patients with Advanced Soft Tissue Sarcomas
Study
EGAS50000000082
-
Sequencing of Ovarian Cancer
Study
EGAS00001007489
-
Sequencing of Breast Cancer
Study
EGAS00001007490
-
Converging and evolving immuno-genomic routes towards immune escape in breast cancer
Study
EGAS00001004956
-
Multimodal epigenetic sequencing analysis for colon cancer
Study
EGAS50000000052
-
MediMer: A versatile do-it-yourself peptide-receptive MHC class I multimer platform for tumor neoantigen-specific T cell detection
Study
EGAS50000000065
-
AVENIO Expanded ctDNA panel sequence alignments (BAMs) from plasma DNA of lung cancer patients from the OSCILLATE trial
Study
EGAS50000000103
-
Immunomodulatory effects and improved outcomes with cisplatin- vs carboplatin-based chemotherapy plus atezolizumab in urothelial cancer
Study
EGAS50000000104
-
Residual ANTXR1+ myofibroblasts after chemotherapy inhibit anti-tumor immunity via YAP1 signaling pathway
Study
EGAS50000000136
-
Evolutionary Trajectories of Small Cell Lung Cancer under Therapy
Study
EGAS50000000169
-
Oxel Pilot Study
Study
EGAS50000000222
-
Prediction of plasma ctDNA fraction and prognostic implications of liquid biopsy in advanced prostate cancer
Study
EGAS50000000211
-
Lung cancer cfDNA dataset DAC
Dac
EGAC00001002994
-
Ovarian cancer cfDNA dataset DAC
Dac
EGAC00001003234
-
Prediction of plasma ctDNA fraction and prognostic implications of liquid biopsy in advanced prostate cancer
Dataset
EGAD50000000303
-
Improved detection of colibactin-induced mutations by genotoxic E. coli in organoids and colorectal cancer
Study
EGAS50000000212
-
WGS of human colorectal cancer organoid exposed to genotoxic pks+ E. coli
Dataset
EGAD50000000304
-
Transcriptomic characterization of the histopathological growth patterns in breast cancer liver metastases
Dataset
EGAD50000000331
-
INCLIVA-CC-WES
Dataset
EGAD50000000293
-
INCLIVA-CC-WES DAC
Dac
EGAC50000000156
-
Endoresist panel sequencing
Dataset
EGAD50000000350
-
RNA-seq data for study 'Smoking-dependent expression alterations in nasal epithelium reveal immune impairment linked to germline variation and lung cancer risk.'
Dataset
EGAD50000000333
-
scRNA sequencing of in vitro generated suppressive myeloid cells using parental and Sialidase expressing A549 cancer cell lines
Dataset
EGAD50000000351
-
Metastatic Breast Cancer Data Access Committee
Dac
EGAC00001003074
-
Somatic mutations of non-malignant T cells
Study
EGAS50000000237
-
INTEGRATIVE MOLECULAR ANALYSIS OF SKIN TUMORS FROM CYLD CUTANEOUS SYNDROME PATIENTS
Study
EGAS50000000247
-
Eribulin efficacy in platinum-resistant and refractory high-grade serous ovarian cancer patient-derived xenograft models
Study
EGAS50000000152
-
Cell-Free DNA Genomic Profiling and its Clinical Implementation in Advanced Prostate Cancer
Dataset
EGAD50000000348
-
Neversmoker lung adenocarcinoma
Study
EGAS50000000232
-
Sensitive circulating tumor DNA based residual disease detection in epithelial ovarian cancer
Dataset
EGAD50000000360
-
RNA sequencing of Non-Small Cell Lung Cancer and adjacent normal tissue (ICON)
Dataset
EGAD50000000361
-
A tumor focused approach to resolving the etiology of DNA mismatch repair deficient tumors classified as suspected Lynch syndrome
Study
EGAS50000000021
-
cell-Free DNA Genomic Profiling and its Clinical Implementation in Advanced Prostate Cancer
Study
EGAS50000000234
-
Genomic gain of EBV's LMP-1 in NKTCL
Study
EGAS50000000260
-
The genomic imprint of cancer therapies helps timing the formation of metastases
Study
EGAS00001003416
-
Nurminen et al ("GP2Men") Study Primary and Metastatic Prostate Cancer Whole Genome Sequence Data
Study
EGAS50000000005
-
Comprehensive NGS Profiling to Enable Detection of ALK Gene Rearrangements and MET Amplifications in Non-Small Cell Lung Cancer
Study
EGAS50000000010
-
The chemotherapeutic CX-5461 is extremely mutagenic and may increase cancer risk
Study
EGAS50000000023
-
Enhancing OSCC Prediction: The Prognostic Power of WPOI and Tumor Budding, and the Limited Impact of Molecular Resection Margins
Study
EGAS50000000074
-
Arcagen – thoracic malignancies
Study
EGAS50000000123
-
Stability of gut microbiome after COVID-19 vaccination in healthy and immuno-compromised individuals
Study
EGAS50000000179